Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism TSC2 inhibitors(TSC complex subunit 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberous Sclerosis | Discovery | US | 19 Apr 2024 |